摘要
目的分析单独抗血小板治疗与联合抗凝治疗在心源性脑梗死患者中的临床疗效。方法随机从我院2017年6—12月收治的心源性脑梗死患者中抽取80例纳入讨论,用随机数字法分为2组,每组40例,对照组接受单独抗血小板治疗,研究组接受单独抗血小板治疗与联合抗凝治疗,观察治疗状况,如疗效、神经缺损功能等,并进行对比。结果研究组治疗总疗效为92.50%,高于对照组70.00%,组间对比,差异有统计学意义(P<0.05)。治疗前NIHSS评分,组间对比,差异无统计学意义(P>0.05);治疗后,研究组低于对照组,差异有统计学意义(P<0.05)。结论临床治疗心源性脑梗死疾病可考虑将抗凝治疗与单独抗血小板方式联合使用,疗效突出,且患者神经缺损功能改善更明显。
Objective To analyze the clinical efcacy of single antiplatelet therapy and combined anticoagulant therapy in patients with cardiogenic cerebral infarction. Methods 80 cases with cardiogenic cerebral infarction from June to December 2017 in our hospital were randomly selected, they were randomly divided into two groups, 40 cases in each group. The control group were received separate antiplatelet therapy, and the study group were received separate antiplatelet therapy and combined anticoagulation therapy. Observe the status of treatment, such as curative efect, function of nerve defect and so on, and compared. Results The total therapeutic efect of the study group was 92.50%, which was higher than that of the control group 70.00%, and the difference between the groups was statistically signifcant （P 〈 0.05）. There was no signifcant diference in NIHSS score before treatment （P 〉 0.05）. After treatment, the study group was lower than the control group, and the diference was statistically signifcant （P 〈 0.05）. Conclusion The clinical treatment of cardiogenic cerebral infarction can consider the combination of anticoagulation therapy and single antiplatelet therapy. The curative effect is prominent, and the neurological deficit function of patients is improved more obviously.
出处
《中国继续医学教育》
2018年第1期100-101,共2页
China Continuing Medical Education
关键词
心源性脑梗死
抗凝治疗
联合
单独抗血小板
疗效
cardiogenic cerebral infarction
anticoagulant therapy
combined
antiplatelet alone
curative efect
